CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population

Clinica Chimica Acta

Volumn 353, Issue 1-2, 2005, Pages 187-192

  Hu, Yong Fang ^a   He, Jun ^a   Chen, Guo Lin ^a   Wang, Dan ^a   Liu, Zhong Qi ^b   Zhang, Che ^a   Duan, Li Fang ^a   Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chinese; CYP3A4; CYP3A5; Cytochrome P450; PCR RFLP

Indexed keywords

CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYP3A5 PROTEIN, HUMAN; CYTOCHROME P450;

ADULT; ANALYTIC METHOD; ARTICLE; CHINESE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME METABOLISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ALLELE; CHINA; GENETICS;

STAPHYLOCOCCUS PHAGE 3A;

ADOLESCENT; ADULT; ALLELES; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 13444291244     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.11.005     Document Type: Article

References (20)

1. F.J. Gonzalez, B.J. Schmid, M. Umeno, O.W. Mcbride, J.P. Hardwick, and U.A. Meyer Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase DNA 7 1988 79 86
2. T. Aoyama, S. Yamano, D.J. Waxman, D.P. Lapenson, U.A. Meyer, and V. Fischer Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine J. Biol. Chem. 264 1989 10388 10395
3. M. Komori, K. Nishio, H. Ohi, M. Kitada, and T. Kamataki Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450 J. Biochem. (Tokyo) 105 1989 161 163
4. T.L. Domanski, C. Finta, J.R. Halpert, and P.G. Zaphiropoulos cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450 Mol. Pharmacol. 59 2001 386 392
5. K.E. Thummel, and G.R. Wilkinson In vitro and in vivo drug interactions involving human CYP3A Annu. Rev. Pharmacol. Toxicol. 38 1998 389 430
6. W.E. Evans, and M.V. Relling Pharmacogenetics: translating functional genomics into rational therapeutics Science 286 1999 487 491
7. V. Ozdemir, W. Kalowa, B.K. Tang, A.D. Paterson, S.E. Walker, and L. Endrenyi Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method Pharmacogenetics 10 2000 373 388
8. D. Dai, J. Tang, R. Rose, E. Hodgson, R.L. Bienstock, and H.W. Mohrenweiser Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos J. Pharmacol. Exp. Ther. 299 2001 825 831
9. P. Kuehl, J. Zhang, Y. Lin, J. Lamba, M. Assem, and J. Schuetz Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Nat. Genet. 27 2001 383 391
10. P.S. Shin, and J.D. Huang Pharmacokinetics of midazolam and 1'-hydroxymidazolam in Chinese with different CYP3A5 genotypes Drug Metab. Dispos. 30 2002 1491 1496
11. B.P. King, J.B. Leathart, E. Mutch, F.M. Williams, and A.K. Daly CYP3A5 phenotype genotype correlations in a British population Br. J. Clin. Pharmacol. 55 2003 625 629
12. N. Blin, and D.W. Stafford A general method for isolation of high molecular weight DNA from eukaryotes Nucleic Acids Res. 3 1976 2303 2308
13. R.H. van Schaik, I.P. van der Heiden, J.N. van den Anker, and J. Lindemans CYP3A5 variant allele frequencies in Dutch Caucasians Clin. Chem. 48 2002 1668 1671
14. I.P. van der Heiden, M. van der Werf, J. Lindemans, and R.H. van Schaik Sequencing: not always the "gold standard" Clin. Chem. 50 2004 248 249
15. S. Fukuen, T. Fukuda, H. Maune, Y. Ikenaga, I. Yamamoto, and T. Inaba Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and*6, in a Japanese population Pharmacogenetics 12 2002 331 334
16. C. Balram, Q. Zhou, Y.B. Cheung, and E.J. Lee CYP3A5*3 and*6 single nucleotide polymorphisms in three distinct Asian populations Eur. J. Clin. Pharmacol. 59 2003 123 126
17. E. Hustert, M. Haberl, O. Burk, R. Wolbold, Y.Q. He, and K. Klein The genetic determinants of the CYP3A5 polymorphism Pharmacogenetics 11 2001 773 779
18. M. Saeki, Y. Saito, T. Nakamura, N. Murayama, S.R. Kim, and S. Ozawa Single nucleotide polymorphisms (SNPs) and haplotype frequencies of CYP3A5 in a Japanese population Human Mutat. 21 2003 653 660
19. T.C. Liu, S.F. Lin, T.P. Chen, and J.G. Chang Polymorphism analysis of CYP3A5 in myeloid leukemia Oncol. Rep. 9 2002 327 329
20. M.R. First, T.J. Schroeder, A.P. Monaco, M.A. Simpson, J.J. Curtis, and V. Armenti Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulation Clin. Transplant. 10 1996 55 59